Clinical Trial Info

Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers

Authored by
Staff

This is an open-label Phase 1 trial to evaluate the safety, tolerability and immunological profile of INO-4800 administered by intradermal (ID) injection followed by electroporation (EP) using CELLECTRA® 2000 device in 120 healthy adult volunteers.